Evidence map›Paper›PMID 24861915›Full record

ArticleMedical oncology (Northwood, London, England)2014

Investigation of the association of hRRM1 and p53R2 gene polymorphisms in head and neck squamous cell carcinomas.

Kadir Serkan Orhan, Ender Coskunpinar, Deniz Kanliada, Yasemin Musteri Oltulu, Bora Basaran, Mehmet Celik, Bedia Cakmakoglu, Kemal Deger

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kadir Serkan OrhanDepartment of ORL and Head and Neck Surgery, Istanbul Faculty of Medicine, Istanbul University, 34390, Capa, Fatih, Istanbul, Turkey, ksorhan@istanbul.edu.tr.
Ender Coskunpinar
Deniz Kanliada
Yasemin Musteri Oltulu
Bora Basaran
Mehmet Celik
Bedia Cakmakoglu
Kemal Deger
Istanbul University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck squamous epithelial cell cancer (HNSCC), the world's fifth most common type of cancers, is associated with short life expectancy and high death rates if not detected in early stages. The aim of this study was to investigate hRRM1 and p53R2 gene polymorphisms by using real-time PCR technique in patients with head and neck cancer. In total, 87 patients with head and neck malignancies and 87 control group who have not any malignancies were included in the study between January 2011 and February 2012 in Istanbul University Faculty of Medicine Department of ORL. In the study, real-time PCR was used to detect hRRM1 (rs12806698 C/A) and p53R2 (rs2290707 G/T) gene polymorphisms in Turkish HNSCC patients and healthy individuals. Genomic DNA isolation was performed according to the kit protocol with spin column. LightCycler 1.5 system was used to perform SNP genotyping using hybridization probes consisting of 3'-fluorescein and a 5'-LightCycler Red labeled pair of oligonucleotide probes. There were significant differences in the distribution of hRRM1 genotypes. Frequency of individuals with hRRM1 AA genotype was higher in patients with less differentiation when compared with well differentiation [p 0.025, Fisher's exact test, odds ratio (OR) 0.140, 95 % confidence intervals (CI) 0.024-0.797]. It is observed that A allele carriers have nearly twofold risk for development of the disease (p = 0.022; χ (2) 5.24; OR 2.02, 95 % CI 1.10-3.72).

Indexed as

AdultCarcinoma, Squamous CellCase-Control StudiesCell Cycle ProteinsCell DifferentiationFemaleGene FrequencyGenetic Predisposition to DiseaseHead and Neck NeoplasmsHumansMaleMiddle AgedPolymorphism, Single NucleotideReal-Time Polymerase Chain ReactionRibonucleoside Diphosphate ReductaseRibonucleotide ReductasesCell Cycle ProteinsRibonucleoside Diphosphate ReductaseRibonucleotide ReductasesRRM1 protein, humanRRM2B protein, humanTumor Suppressor Proteins

Identifiers

PMID24861915
OpenAlexW2333770018

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.